Monday
June 2, 2025
1:25 AM ET
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Thursday
May 1, 2025
7:00 AM ET
Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Friday
April 25, 2025
8:00 AM ET
Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Thursday
February 13, 2025
7:00 AM ET
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results
Wednesday
February 5, 2025
8:00 AM ET
Blueprint Medicines to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025